User profiles for "author:Julia C Gage"
Julia C GageNational Cancer Institute Verified email at nih.gov Cited by 9018 |
Human papillomavirus testing in the prevention of cervical cancer
M Schiffman, N Wentzensen… - Journal of the …, 2011 - academic.oup.com
Strong evidence now supports the adoption of cervical cancer prevention strategies that
explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV) …
explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV) …
Genotyping for human papillomavirus types 16 and 18 in women with minor cervical lesions: a systematic review and meta-analysis
Background: High-risk human papillomavirus (hrHPV) testing to triage women with minor
cervical lesions generates many referrals. Purpose: To evaluate the accuracy of genotyping …
cervical lesions generates many referrals. Purpose: To evaluate the accuracy of genotyping …
Number of cervical biopsies and sensitivity of colposcopy
JC Gage, VW Hanson, K Abbey, S Dippery… - Obstetrics & …, 2006 - journals.lww.com
OBJECTIVE: To examine the influence that type of medical training and number of biopsies
have on sensitivity of colposcopically guided biopsies. METHODS: Among 408 women with …
have on sensitivity of colposcopically guided biopsies. METHODS: Among 408 women with …
An observational study of deep learning and automated evaluation of cervical images for cancer screening
Background Human papillomavirus vaccination and cervical screening are lacking in most
lower resource settings, where approximately 80% of more than 500 000 cancer cases …
lower resource settings, where approximately 80% of more than 500 000 cancer cases …
Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test
JC Gage, M Schiffman, HA Katki… - Journal of the …, 2014 - academic.oup.com
Primary human papillomavirus (HPV) testing (without concurrent Pap tests) every 3 years is
under consideration in the United States as an alternative to the two recommended cervical …
under consideration in the United States as an alternative to the two recommended cervical …
[HTML][HTML] Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines
Objective The 2019 American Society for Colposcopy and Cervical Pathology Risk-Based
Management Consensus Guidelines for the management of cervical cancer screening …
Management Consensus Guidelines for the management of cervical cancer screening …
Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines
HA Katki, M Schiffman, PE Castle… - Journal of lower …, 2013 - journals.lww.com
Objective In 2012, the US Preventive Services Task Force (USPSTF) and a consensus of 25
organizations endorsed concurrent cytology and human papillomavirus (HPV) testing …
organizations endorsed concurrent cytology and human papillomavirus (HPV) testing …
World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen‐and‐treat strategies to prevent cervical cancer
N Santesso, RA Mustafa… - … of Gynecology & …, 2016 - Wiley Online Library
Background It is estimated that 1%–2% of women develop cervical intraepithelial neoplasia
grade 2–3 (CIN 2–3) annually worldwide. The prevalence among women living with HIV is …
grade 2–3 (CIN 2–3) annually worldwide. The prevalence among women living with HIV is …
[HTML][HTML] A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection
Background Vaginal pH is related to genital tract inflammation and changes in the bacterial
flora, both suggested cofactors for persistence of human papillomavirus (HPV) infection. To …
flora, both suggested cofactors for persistence of human papillomavirus (HPV) infection. To …
[HTML][HTML] A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
M Demarco, N Hyun, O Carter-Pokras… - …, 2020 - thelancet.com
Background HPV testing is replacing cytology for cervical cancer screening because of
greater sensitivity and superior reassurance following negative tests for the dozen HPV …
greater sensitivity and superior reassurance following negative tests for the dozen HPV …